- 1. (+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
- [An imidazole derivate and active d-isomer of medetomidine with analgesic, anxiolytic and sedative properties. Dexmedetomidine selectively binds to presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibit sympathetic activity, thereby leading to sedation and anxiolysis. The analgesic effect of this agent is mediated by binding to alpha2-adrenoceptors in the spinal cord. ( NCI )] (UMLS (NCI) C0113293) =Organic Chemical; Pharmacologic Substance =imidazole;
[CN309] SEDATIVES/HYPNOTICS, OTHER =DEXMEDETOMIDINE HCL | - 39. Salmonella infection
- [infections with bacteria of the genus Salmonella ( CSP )] (UMLS (CSP) C0036117) =Disease or Syndrome ;
=Enterobacteriaceae disease;
=SALMONELLA ENTERITIS;
typhoid;
Paratyphoid Fever;
SALMONELLA ENTERITIS;
Salmonella Infections, Animal;
typhoid |
- 2. (-)-Salbutamol Hydrochloride
- [The hydrochloride salt form of levalbuterol, a relatively selective sympathomimetic beta2 receptor agonist with bronchodilator activity. Levalbuterol hydrochloride binds to beta2-adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, thereby increasing the production of cyclic-3', 5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased cyclic AMP concentrations also inhibit the release of inflammatory mediators from mast cells. ( NCI )] (UMLS (NCI) C0772502) 1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, Hydrochloride,(alpha1R)-;
LEVALBUTEROL HYDROCHLORIDE;
=Organic Chemical; Pharmacologic Substance | - 40. SALMONELLA MENINGITIS
- [ ] (UMLS (ICD9CM) C0152488) =Disease or Syndrome
|
- 3. (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- [A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. ( NCI )] (UMLS (NCI) C0377265) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
etiracetam =LEVETIRACETAM 500 MG;
LEVETIRACETAM 250 MG;
LEVETIRACETAM 750 MG;
| - 41. SALMONELLA OSTEOMYELITIS
- [ ] (UMLS (ICD9CM) C0152491) =Disease or Syndrome
|
- 4. (S)-alpha-Methylbenzeneethanamine Sulfate
- [The salt of the dextro-isomer of amphetamine and sympathomimetic amine with CNS stimulating properties. Dextroamphetamine sulphate acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from nerve terminals in the brain and inhibits their uptake. This leads to an increase in motor activity, causes euphoria, mental alertness and excitement and suppresses appetite. This drug causes dependence and may cause an increase in heart rate and blood pressure. It is used in the treatment of narcolepsy and attention deficit hyperactivity disorder. ( NCI )] (UMLS (NCI) C0011810) =Organic Chemical; Pharmacologic Substance ;
=Dextroamphetamine;
=DEXTROAMPHETAMINE SULFATE 1.25 MG;
DEXTROAMPHETAMINE SULFATE 15 MG;
DEXTROAMPHETAMINE SULFATE 5 MG;
DEXTROAMPHETAMINE SULFATE 5 MG/5ML;
DEXTROAMPHETAMINE SULFATE 7.5 MG;
DEXTROAMPHETAMINE SULFATE 10 MG;
DEXTROAMPHETAMINE SULFATE 2.5 MG;
DEXTROAMPHETAMINE SULFATE 3.75 MG;
| - 42. SALMONELLA PNEUMONIA
- [ ] (UMLS (ICD9CM) C0152489) =Disease or Syndrome
|
- 5. S-Allylcysteine
- (UMLS (NCI) C0084440) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 43. SALMONELLA SEPTICEMIA
- [ ] (UMLS (ICD9CM) C0152486) =Disease or Syndrome
|
- 6. Salagen
- (UMLS (NCI) C0699930) =Organic Chemical; Pharmacologic Substance
| - 44. Salmonella typhi
- [serotype of the species, Salmonella enterica, and is the etiologic agent of typhoid fever. ( CSP )] (UMLS (CSP) C0036125) =Bacterium ;
=Salmonella;
|
- 7. salamander
- [ ] (UMLS (CSP) C0086949) =Amphibian
| - 45. Salmonella typhimurium
- [serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans; it also causes paratyphoid fever. ( CSP )] (UMLS (CSP) C0036126) =Bacterium ;
=Salmonella;
|
- 8. salary
- [ ] (UMLS (CSP) C0036064) =Quantitative Concept ;
| - 46. Salmonella vaccine
- [vaccines or candidate vaccines used to prevent infection with salmonella; includes vaccines used to prevent typhoid or paratyphoid fever, and vaccines used to prevent nontyphoid salmonellosis. ( CSP )] (UMLS (CSP) C0597420) =Pharmacologic Substance; Immunologic Factor ;
=bacterial vaccine;
|
- 9. Sale
- [Transfer of ownership for a product for financial compensation. ( HL7V3.0 )] (UMLS (HL7) C1555584) =Idea or Concept =Transfer;
| - 47. Salmonella VNP20009
- [A genetically modified Salmonella bacterium that is injected into the tumor. It is being studied for its ability to shrink solid tumors. ( NCI )] (UMLS (NCI) C0879622) VNP 20009;
VNP20009;
=Bacterium |
- 10. salicylazosulfapyride
- [ ] (UMLS (CSP) C0599504) =Organic Chemical; Pharmacologic Substance
| - 48. Salmonidae
- [A family of anadromous fish comprising SALMON; TROUT; whitefish; and graylings. They are the most important food and game fishes. Their habitat is the northern Atlantic and Pacific, both marine and inland, and the Great Lakes. (Nelson: Fishes of the World, 1976, p97) ( MSH )] (UMLS (CSP) C0036129) =Fish ;
|
- 11. saline
- [any aqueous salt solution; usually means normal or physiological saline, which is 0.9% sodium chloride, and is used as a base for culture media and buffers, and as an injection vehicle or control. ( CSP )] (UMLS (NCI) C0036082) =Clinical Drug ;
=water solution;
| - 49. salpingectomy
- [Surgery to remove part or all of the fallopian tube(s). ( NCI )] (UMLS (CSP) C0041271) =Therapeutic or Preventive Procedure
|
- 12. Salinosporamide A
- [A gamma-lactam related, naturally occurring salinosporamide, isolated from the marine bacterium Salinospora sp. (old taxon actinomycete), with antineoplastic activity. Salinosporamide A irreversibly binds to and inhibits the 20S catalytic core subunit of proteasome, which is an ATP-dependent multi-subunit proteolytic complex that mediates the degradation of ubiquitinated proteins during normal cell growth and stress responses in order to balance cellular metabolism. Inhibition of ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins. This leads to a disruption of cellular processes and results in cell cycle arrest, induction of apoptosis, and inhibition of tumor growth and angiogenesis. ( NCI )] (UMLS (NCI) C1259854) Salinosporin A =Organic Chemical; ;
| - 50. salpingitis
- [inflammation of the fallopian tubes. ( CSP )] (UMLS (CSP) C0036130) =Disease or Syndrome ;
=Adnexitis;
Fallopian Tube Diseases;
daleket haagan PID;
|
- 13. Salishan
- (UMLS (HL7) C1698688) =Language ;
=AmericanIndianAlaskaNativeLanguages;
=InteriorSalish;
CentralSalish;
Tsamosan;
| - 51. Salpingitis and oophoritis not specified as acute, subacute, or chronic
- (UMLS (ICD9CM) C0036133) =Disease or Syndrome ;
|
- 14. Saliva
- (UMLS (HL7) C1546769) =Intellectual Product =Specimen Source Codes;
| - 52. Salpingitis Isthmica Nodosa
- (UMLS (NCI) C0269043) =Disease or Syndrome
|
- 15. Saliva
- (UMLS (HL7) C1608524) =Body Substance ;
=SpecimenEntityType;
| - 53. salpingo-oophorectomy
- [(sal-PIN-go o-o-for-EK-toe-mee) Surgical removal of the fallopian tubes and ovaries. ( NCI )] (UMLS (NCI) C0036132) =Therapeutic or Preventive Procedure ;
|
- 16. Salivart
- [An aerosol spray and oral moisturizer, produced by Xenex laboratories, containing artificial saliva used to relieve xerostomia. Salivart coats mucosa and moisturizes oral tissue, thereby relieving dry mouth and throat. ( NCI )] (UMLS (NCI) C0723201) =Pharmacologic Substance; Inorganic Chemical ;
| - 54. SALPINGO-OOPHOROSTOMY
- (UMLS (ICD9CM) C0195551) =Therapeutic or Preventive Procedure
|
- 17. Salivary
- [Salivary; of or relating to saliva. ( NCI )] (UMLS (NCI) C0442040) =Spatial Concept
| - 55. SALPINGO-UTEROSTOMY
- [ ] (UMLS (ICD9CM) C0177178) =Therapeutic or Preventive Procedure
|
- 18. Salivary Gland Adenosquamous Carcinoma
- (UMLS (NCI) C1335894) =Neoplastic Process ;
| - 56. SALPINGOSTOMY
- [Formation of an artificial opening in a fallopian tube. ( MSH )] (UMLS (ICD9CM) C0036136) =Therapeutic or Preventive Procedure ;
|
- 19. Salivary Gland Cystadenoma
- [An uncommon benign epithelial tumor, characterized by predominantly unicystic or multicystic growth; there is focal intraluminal papillary proliferation of the lining epithelium. Nearly half occur in the parotid gland. In the minor salivary glands, women are affected more than men. In the major salivary glands, cystadenomas present as slowly enlarging, asymptomatic masses that may be slightly compressible. Cystadenocarcinoma is the malignant counterpart. — 2003 ( NCI )] (UMLS (NCI) C1335898) =Neoplastic Process ;
| - 57. SALPINGOTOMY
- (UMLS (ICD9CM) C0195475) =Therapeutic or Preventive Procedure
|
- 20. Salivary Gland Ductal Papilloma
- (UMLS (NCI) C1335899) =Neoplastic Process ;
| - 58. Salpingotomy and salpingostomy
- [ ] (UMLS (ICD9CM) C0565840) =Therapeutic or Preventive Procedure
|
- 21. Salivary Gland Epithelial Myoepithelial Carcinoma
- (UMLS (NCI) C1335900) =Neoplastic Process ;
| - 59. salt
- [any compound of a base and an acid; any compound of an acid some of whose replaceable hydrogen atoms have been substituted. ( CSP )] (UMLS (CSP) C0036140) =Chemical Viewed Structurally ;
=Chemical;
=CHLORIDE (AS POTASSIUM);
Salt |
- 22. Salivary Gland Intraductal Papilloma
- [An intraluminal papillary proliferation that causes unicystic dilatation of the duct and may have features in common with papillary cystadenoma. It is quite rare, and involves almost exclusively the excretory ducts of intraoral minor salivary glands. It presents as an asymptomatic submucosal swelling. — 2003 ( NCI )] (UMLS (NCI) C1335901) =Neoplastic Process ;
| - 60. Salt
- [NaCl; plays an important biological role in maintaining the osmotic tension of blood and tissues; for the sodium salt that is commonly used to season food use DIETARY SODIUM. ( CSP )] (UMLS (NCI) C0037494) =Pharmacologic Substance; Biologically Active Substance; Inorganic Chemical =Chlorides;
salt;
[TN404] SODIUM;
Sodium Compounds =xylometazoline 1 MG/ML Nasal Solution;
MERITENE POWDER (CHOCOLATE);
MERITENE POWDER (MILK CHOCOLATE);
MERITENE POWDER (VANILLA);
SODIUM CHLORIDE 5 %;
Polyvinyl Alcohol 0.14 ML/ML / Povidone 6 MG/ML Ophthalmic Solution;
Naphazoline 0.5 More… |
- 23. Salivary Gland Inverted Ductal Papilloma
- [A very rare benign tumor of the minor salivary glands, characterized by a luminal papillary proliferation that arises at the junction of the salivary gland duct and the oral mucosal surface epithelium and expands as a nodular mass into the lamina propria. It presents as an asymptomatic mucosal swelling. — 2003 ( NCI )] (UMLS (NCI) C1335902) =Neoplastic Process ;
| - 61. salt bacteria
- [ ] (UMLS (CSP) C0598547) =Archaeon ;
|
- 24. Salivary Gland Monomorphic Adenoma
- [A benign epithelial neoplasm arising from the salivary glands. It is characterized by the presence of a monomorphic cellular infiltrate. ( NCI )] (UMLS (NCI) C0205649) =Neoplastic Process
| - 62. salt balance
- [ ] (UMLS (CSP) C0598357) =Organism Function ;
|
- 25. Salivary Gland Myoepithelial Carcinoma
- (UMLS (NCI) C1335904) =Neoplastic Process
| - 63. salt gland
- [compound tubular gland, located around the eyes and nasal passages in marine animals and birds, the physiology of which figures in water-electrolyte balance; also the rectal gland or rectal salt gland in the dogfish shark which is attached at the junction of the intestine and cloaca and aids the kidneys in removing excess salts from the blood. ( CSP )] (UMLS (CSP) C0036139) =Body Part, Organ, or Organ Component ;
=exocrine gland;
|
- 26. Salivary Gland Polymorphous Low Grade Adenocarcinoma
- [A low grade malignant epithelial neoplasm arising from the salivary gland. It usually arises from the oral cavity, with approximately 60% of the cases involving the palate. The most common presenting sign is a painless mass in the palate. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. There is a variety of morphologic patterns which may be present within an individual tumor, including lobular, papillary, papillary-cystic, cribriform, and trabecular pattern. It usually has a favorable clinical outcome and a low metastatic potential. ( NCI )] (UMLS (NCI) C1335907) Salivary Gland Terminal Duct Adenocarcinoma =Neoplastic Process
| - 64. salt hypertension from excess dietary salt
- [ ] (UMLS (CSP) C0597851) =Pathologic Function ;
|
- 27. Salivary Gland Sebaceous Adenoma
- [A rare, benign, encapsulated epithelial tumor composed of cells that form solid, variably shaped islands and cysts, both showing focal sebaceous differentiation. The mean age of patients is reported to be 58 years, and most tumors occur in the parotid gland. There is a male predominance. Most patients are asymptomatic. — 2003 ( NCI )] (UMLS (NCI) C1335908) =Neoplastic Process
| - 65. salt intake
- [ingestion of salt; includes the behavior of eating salty foods. ( CSP )] (UMLS (CSP) C0489767) =Organism Attribute ;
=Ingestive Behavior;
|
- 28. Salivary Gland Sebaceous Lymphadenoma
- [A rare benign epithelial tumor composed of irregular, proliferating nests and islands of epithelium, including solid and gland-like sebaceous elements, surrounded by lymphoid stroma. Most occur in the parotid gland. Symptoms include a progressively enlarging, painless mass. Sebaceous lymphadenocarcinoma is the malignant counterpart. — 2003 ( NCI )] (UMLS (NCI) C1335909) Sebaceous Lymphadenoma of Salivary Gland;
Sebaceous Lymphadenoma of the Salivary Gland;
=Neoplastic Process | - 66. Salt River Pima-Maricopa Indian Community of the S
- (UMLS (HL7) C1554468) =Population Group =NativeEntityContiguous;
|
- 29. Salivary Gland Sialadenoma Papilliferum
- [An uncommon exophytic papillary proliferation that involves mucosal surface epithelium and salivary duct epithelium. It is exceptional among salivary gland neoplasms because it manifests as an exophytic papillary excrescence of the mucosa, rather than as a submucosal or intraglandular mass. It most often affects the hard or soft palate. It is generally asymptomatic. — 2003 ( NCI )] (UMLS (NCI) C1335910) =Neoplastic Process
| - 67. salt water environment
- [living in or surrounded by water containing a large amount of salt. ( CSP )] (UMLS (CSP) C0178838) =Spatial Concept =water environment;
|
- 30. Salivary Gland Sialoblastoma
- [A rare, congenital or perinatal, aggressive and potentially low-grade malignant, basaloid neoplasm that occurs in the major salivary glands. It typically presents as a mass over the angle of the mandible. Most involve the parotid gland. — 2003 ( NCI )] (UMLS (NCI) C1335911) =Neoplastic Process
| - 68. salt water organism
- [ ] (UMLS (CSP) C0599384) =Organism
|
- 31. salivary sulfated glycoprotein
- [ ] (UMLS (CSP) C0144040) =Amino Acid, Peptide, or Protein; Carbohydrate ;
| - 69. salty
- [ ] (UMLS (CSP) C1537053) =Qualitative Concept ;
|
- 32. salivation
- [secretion of saliva. ( CSP )] (UMLS (CSP) C0036104) =Organ or Tissue Function ;
=gastrointestinal function;
autonomic reflex | - 70. Saluki
- [The Saluki has a slim, greyhound-like body with long feathering on the ears and tail. They have an unusual gait when they are at top speed: all four of their legs are in the air at the same time. The coat comes in black and tan, fawn, white, cream, gold and red, as well as various combinations of these. Some Salukis have a patch of white in the middle of the forehead. The ears are long and hanging and the neck is flexible. The feet are thickly haired between the toes for protection from rough terrain. Height: 23-28 inches (58-71 cm.) Weight: 29-66 pounds (13-30 kg.) ( NCI )] (UMLS (NCI) C0324435) =Mammal
|
- 33. SALMETEROL
- [A highly selective, long-acting beta2-adrenergic agonist with bronchodilatory activity. Salmeterol's benzene moiety resembles the structure of catecholamines, and occupies the active site of beta2-adrenergic receptor, while the long, lipophilic side chain of salmeterol, binds to the so called 'exosite' near the beta2-receptors. The binding at the exosite allows the active portion of the molecule to remain at the receptor site and continually engage and disengage with the receptor, therefore providing a long duration of action. This agent stimulates intracellular adenyl cyclase to catalyze the conversion of adenosine triphosphate to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels result in relaxation of bronchiolar smooth muscle, bronchodilation and increased bronchial airflow. ( NCI )] (UMLS (NCI) C0073992) =Organic Chemical; Pharmacologic Substance ;
=albuterol;
[RE102] BRONCHODILATORS, SYMPATHOMIMETIC,INHALATION =Salmeterol Xinafoate | - 71. saluresis
- [excretion of sodium and chloride ions in the urine. ( CSP )] (UMLS (CSP) C0178839) =Organ or Tissue Function =kidney function;
|
- 34. Salmeterol Xinafoate
- (UMLS (NCI) C0245531) =Organic Chemical; Pharmacologic Substance ;
=SALMETEROL;
=SALMETEROL XINAFOATE 50 MCG/ACTUAT;
SALMETEROL XINAFOATE 50 MCG;
| - 72. Salvadoran
- (UMLS (HL7) C1171364) =Population Group ;
=Central American;
|
- 35. salmon
- [Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed). ( MSH )] (UMLS (CSP) C0036110) =Fish ;
| - 73. salvage therapy
- [Treatment that is given after the cancer has not responded to other treatments. ( NCI )] (UMLS (NCI) C0085405) =Therapeutic or Preventive Procedure ;
|
- 36. Salmonella
- [genus of gram negative, facultatively anaerobic, rod shaped bacteria that utilizes citrate as a sole carbon source; it is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia; food poisoning is the most common clinical manifestation; organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility. ( CSP )] (UMLS (CSP) C0036111) =Bacterium ;
=coliform bacilli;
=Salmonella typhi;
Salmonella typhimurium | - 74. Salvation Army
- (UMLS (HL7) C1699569) =Population Group ;
=Religious Affiliation;
|
- 37. SALMONELLA ARTHRITIS
- [ ] (UMLS (ICD9CM) C0152490) =Disease or Syndrome
| - 75. [1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-1,2,6,7,8,8a-Hexahydro-beta,!d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic Acid
- [A synthetic lipid-lowering agent. Pravastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Pravastatin lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04) ( NCI )] (UMLS (NCI) C0085542) =Organic Chemical; Pharmacologic Substance =[CV350] ANTILIPEMIC AGENTS;
naphthalene =PRAVASTATIN SODIUM;
PRAVASTATIN 40 MG;
PRAVASTATIN 20 MG;
PRAVASTATIN 80 MG;
|
- 38. SALMONELLA ENTERITIS
- [poisoning caused by ingestion of food harboring species of Salmonella; conditions of raising, shipping, slaughtering, and marketing of domestic animals contribute to the spread of this bacterium in the food supply. ( CSP )] (UMLS (ICD9CM) C0036114) =Disease or Syndrome ;
=food poisoning;
Salmonella infection;
bacterial food poisoning;
| - 76. [1S-[1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta]]-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2,2-dimethylbutanoate
- [a derivative of lovastatin and inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG coA reductase), a rate limiting enzyme in the biosynthesis of cholesterol. ( CSP )] (UMLS (NCI) C0074554) =Organic Chemical; Pharmacologic Substance ;
=[CV350] ANTILIPEMIC AGENTS;
(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester =SIMVASTATIN 10 MG;
SIMVASTATIN 20 MG;
SIMVASTATIN 40 MG;
SIMVASTATIN 80 MG;
SIMVASTATIN 5 MG;
|
home
